Matinas BioPharma Holdings Inc (NYSE:MTNB) was the target of a large decline in short interest in July. As of July 31st, there was short interest totalling 3,548,526 shares, a decline of 15.0% from the July 14th total of 4,176,369 shares. Based on an average trading volume of 276,741 shares, the days-to-cover ratio is currently 12.8 days. Currently, 5.4% of the company’s stock are sold short.

Shares of Matinas BioPharma Holdings (MTNB) opened at 1.36 on Thursday. The stock’s market cap is $124.30 million. The company’s 50-day moving average is $1.79 and its 200 day moving average is $2.59. Matinas BioPharma Holdings has a 1-year low of $0.63 and a 1-year high of $3.99.

WARNING: “Matinas BioPharma Holdings Inc (MTNB) Short Interest Update” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at

Matinas BioPharma Holdings Company Profile

Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections.

Receive News & Stock Ratings for Matinas BioPharma Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma Holdings Inc and related stocks with our FREE daily email newsletter.